Skip to main content
Clinical Trials/ACTRN12619000174189
ACTRN12619000174189Not yet recruiting未知

Exercise as medicine for heart failure: A novel intervention to improve outcomes

The University of western Australia0 sites100 target enrollmentStarted: February 6, 2019Last updated:
Conditions

Trial Snapshot

Phase
未知
Status
Not yet recruiting
Enrollment
100

Study Overview

Brief Summary

No summary available.

Study Design

Study Type
Interventional
Allocation
Randomised controlled trial
Primary Purpose
Treatment
Masking
Blinded (masking used)

Eligibility Criteria

Ages
18 Years to o limit (—)
Sex
All

Inclusion Criteria

  • NYHA Class II-IIIb with systolic dysfunction (HFrEF, EF <40%).
  • Willing and able to sign written informed consent prior to trial entry
  • Suitable to participate in a 16-week exercise training program, as determined by the medical history and physical examination

Exclusion Criteria

  • Current smoking or smoking in the past 12 months,
  • Renal impairment (stage 4 or 5 CKD),
  • Exercise-induced ischaemia at a low workload (<3 METS),
  • Hypertension (>165/95mmHg)
  • Diagnosed peripheral artery disease

Investigators

Similar Trials

Exercise as medicine for heart failure | Clinical Trial